Dr Jaffar Khan (National Heart, Lung and Blood Institute, Washington, DC, US) discusses the latest results from the BASILICA trial and the prevention of coronary artery obstruction from TAVR.
Filmed on-site at CRT 2019 by Radcliffe Cardiology.
1. Why did you perform this feasibility study?
2. What was the study design and the endpoints?
3. What were your findings?
Videographer: Tom Green
Educational Lead: Liam O'Neill, Chief Operating Officer